Reviews
Systematic reviews
Search a topic, title, author or review id. The Findings tab shows what the reviews found for the same words, grouped by question; the Studies tab shows the primary studies they include.
17 reviews, newest first
Inhaled corticosteroids with combination inhaled long‐acting beta2‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease
Cochraneheadline outcomes only
9 findings
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
Cochraneheadline outcomes only
7 findings
Addition of long‐acting beta2 agonists or long‐acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta‐analysis
Cochraneheadline outcomes only
43 findings
Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
Cochraneheadline outcomes only
7 findings
Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma
Cochraneheadline outcomes only
7 findings
Combination inhaled steroid and long‐acting beta₂‐agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
Cochraneheadline outcomes only
7 findings
Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta₂‐agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
Cochraneheadline outcomes only
7 findings
Addition of long‐acting beta₂‐agonists to inhaled corticosteroids for chronic asthma in children
Cochraneheadline outcomes only
14 findings
Stopping long‐acting beta₂‐agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids
Cochraneheadline outcomes only
7 findings
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta₂‐agonists (LABA) for adults with asthma
Cochraneheadline outcomes only
7 findings
Addition to inhaled corticosteroids of long‐acting beta₂‐agonists versus anti‐leukotrienes for chronic asthma
Cochraneheadline outcomes only
7 findings
Inhaled anticholinergics and short‐acting beta₂‐agonists versus short‐acting beta2‐agonists alone for children with acute asthma in hospital
Cochraneheadline outcomes only
6 findings
Combination inhaled corticosteroids and long‐acting beta₂‐agonists for children and adults with bronchiectasis
Cochraneheadline outcomes only
4 findings
Combined inhaled anticholinergics and short‐acting beta₂‐agonists for initial treatment of acute asthma in children
Cochraneheadline outcomes only
1 finding
Combined corticosteroid and long‐acting beta₂‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease
Cochraneheadline outcomes only
7 findings
Addition of intravenous aminophylline to inhaled beta₂‐agonists in adults with acute asthma
Cochraneheadline outcomes only
6 findings
Addition of intravenous beta₂‐agonists to inhaled beta₂‐agonists for acute asthma
Cochraneheadline outcomes only
4 findings